FDG-PET in Follicular Lymphoma Management

18-Fluoro-deoxyglucose positron emission tomography/computerised tomography (FDG PET/CT) is commonly used in the management of patients with lymphomas and is recommended for both initial staging and response assessment after treatment in patients with diffuse large B-cell lymphoma and Hodgkin lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodet-Milin, C., Eugène, T., Gastinne, T., Frampas, E., Le Gouill, S., Kraeber-Bodéré, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413977/
https://www.ncbi.nlm.nih.gov/pubmed/22899920
http://dx.doi.org/10.1155/2012/370272
_version_ 1782240126221418496
author Bodet-Milin, C.
Eugène, T.
Gastinne, T.
Frampas, E.
Le Gouill, S.
Kraeber-Bodéré, F.
author_facet Bodet-Milin, C.
Eugène, T.
Gastinne, T.
Frampas, E.
Le Gouill, S.
Kraeber-Bodéré, F.
author_sort Bodet-Milin, C.
collection PubMed
description 18-Fluoro-deoxyglucose positron emission tomography/computerised tomography (FDG PET/CT) is commonly used in the management of patients with lymphomas and is recommended for both initial staging and response assessment after treatment in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Despite the FDG avidity of follicular lymphoma (FL), FDG PET/CT is not yet applied in standard clinical practice for patients with FL. However, FDG PET/CT is more accurate than conventional imaging for initial staging, often prompting significant management change, and allows noninvasive characterization to guide assessment of high-grade transformation. For restaging, FDG PET/CT assists in distinguishing between scar tissue and viable tumors in residual masses and a positive PET after induction treatment would seem to predict a shorter progression-free survival.
format Online
Article
Text
id pubmed-3413977
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34139772012-08-16 FDG-PET in Follicular Lymphoma Management Bodet-Milin, C. Eugène, T. Gastinne, T. Frampas, E. Le Gouill, S. Kraeber-Bodéré, F. J Oncol Review Article 18-Fluoro-deoxyglucose positron emission tomography/computerised tomography (FDG PET/CT) is commonly used in the management of patients with lymphomas and is recommended for both initial staging and response assessment after treatment in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Despite the FDG avidity of follicular lymphoma (FL), FDG PET/CT is not yet applied in standard clinical practice for patients with FL. However, FDG PET/CT is more accurate than conventional imaging for initial staging, often prompting significant management change, and allows noninvasive characterization to guide assessment of high-grade transformation. For restaging, FDG PET/CT assists in distinguishing between scar tissue and viable tumors in residual masses and a positive PET after induction treatment would seem to predict a shorter progression-free survival. Hindawi Publishing Corporation 2012 2012-07-30 /pmc/articles/PMC3413977/ /pubmed/22899920 http://dx.doi.org/10.1155/2012/370272 Text en Copyright © 2012 C. Bodet-Milin et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Bodet-Milin, C.
Eugène, T.
Gastinne, T.
Frampas, E.
Le Gouill, S.
Kraeber-Bodéré, F.
FDG-PET in Follicular Lymphoma Management
title FDG-PET in Follicular Lymphoma Management
title_full FDG-PET in Follicular Lymphoma Management
title_fullStr FDG-PET in Follicular Lymphoma Management
title_full_unstemmed FDG-PET in Follicular Lymphoma Management
title_short FDG-PET in Follicular Lymphoma Management
title_sort fdg-pet in follicular lymphoma management
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413977/
https://www.ncbi.nlm.nih.gov/pubmed/22899920
http://dx.doi.org/10.1155/2012/370272
work_keys_str_mv AT bodetmilinc fdgpetinfollicularlymphomamanagement
AT eugenet fdgpetinfollicularlymphomamanagement
AT gastinnet fdgpetinfollicularlymphomamanagement
AT frampase fdgpetinfollicularlymphomamanagement
AT legouills fdgpetinfollicularlymphomamanagement
AT kraeberboderef fdgpetinfollicularlymphomamanagement

Ejemplares similares